Analysts expect Crescent Capital BDC to report Q2 2026 revenue of $37.11 million and EPS of $0.37, while the current stock price of $11.90 remains below the average analyst price target of $13.90. The key story for this quarter is the health of the company's credit quality and portfolio non-accruals following a volatile first quarter.
Investors are particularly focused on the impact of a newly implemented lower fee structure designed to support net investment income (NII) margins. Recent insider share purchases and a strong dividend yield of over 14% have also bolstered sentiment despite the stock trading near its 52-week lows.